These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 26246172)
21. Impact of volume and location of irradiated rectum wall on rectal blood loss after radiotherapy of prostate cancer. Koper PC; Heemsbergen WD; Hoogeman MS; Jansen PP; Hart GA; Wijnmaalen AJ; van Os M; Boersma LJ; Lebesque JV; Levendag P Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1072-82. PubMed ID: 15001247 [TBL] [Abstract][Full Text] [Related]
22. Dose-volume analysis of predictors for chronic rectal toxicity after treatment of prostate cancer with adaptive image-guided radiotherapy. Vargas C; Martinez A; Kestin LL; Yan D; Grills I; Brabbins DS; Lockman DM; Liang J; Gustafson GS; Chen PY; Vicini FA; Wong JW Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1297-308. PubMed ID: 16029785 [TBL] [Abstract][Full Text] [Related]
23. Prostate external beam radiotherapy combined with high-dose-rate brachytherapy: dose-volume parameters from deformably-registered plans correlate with late gastrointestinal complications. Moulton CR; House MJ; Lye V; Tang CI; Krawiec M; Joseph DJ; Denham JW; Ebert MA Radiat Oncol; 2016 Oct; 11(1):144. PubMed ID: 27799048 [TBL] [Abstract][Full Text] [Related]
24. Role of principal component analysis in predicting toxicity in prostate cancer patients treated with hypofractionated intensity-modulated radiation therapy. Vesprini D; Sia M; Lockwood G; Moseley D; Rosewall T; Bayley A; Bristow R; Chung P; Ménard C; Milosevic M; Warde P; Catton C Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e415-21. PubMed ID: 21477939 [TBL] [Abstract][Full Text] [Related]
25. Patient-reported toxicity correlated to dose-volume histograms of the rectum in radiotherapy of the prostate. Taussky D; Schneider U; Rousson V; Pescia R Am J Clin Oncol; 2003 Oct; 26(5):e144-9. PubMed ID: 14528089 [TBL] [Abstract][Full Text] [Related]
26. Intensity modulated proton and photon therapy for early prostate cancer with or without transperineal injection of a polyethylen glycol spacer: a treatment planning comparison study. Weber DC; Zilli T; Vallee JP; Rouzaud M; Miralbell R; Cozzi L Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):e311-8. PubMed ID: 22999271 [TBL] [Abstract][Full Text] [Related]
27. Grading-system-dependent volume effects for late radiation-induced rectal toxicity after curative radiotherapy for prostate cancer. van der Laan HP; van den Bergh A; Schilstra C; Vlasman R; Meertens H; Langendijk JA Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1138-45. PubMed ID: 17931794 [TBL] [Abstract][Full Text] [Related]
28. Clinical toxicities and dosimetric parameters after whole-pelvis versus prostate-only intensity-modulated radiation therapy for prostate cancer. Deville C; Both S; Hwang WT; Tochner Z; Vapiwala N Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):763-72. PubMed ID: 20171807 [TBL] [Abstract][Full Text] [Related]
29. Statistical simulations to estimate motion-inclusive dose-volume histograms for prediction of rectal morbidity following radiotherapy. Thor M; Apte A; Deasy JO; Muren LP Acta Oncol; 2013 Apr; 52(3):666-75. PubMed ID: 23205746 [TBL] [Abstract][Full Text] [Related]
30. Quantifying cell migration distance as a contributing factor to the development of rectal toxicity after prostate radiotherapy. Munbodh R; Jackson A Med Phys; 2014 Feb; 41(2):021724. PubMed ID: 24506615 [TBL] [Abstract][Full Text] [Related]
31. A cylindrical model of the rectum: comparing dose-volume, dose-surface and dose-wall histograms in the radiotherapy of prostate cancer. Fiorino C; Gianolini S; Nahum AE Phys Med Biol; 2003 Aug; 48(16):2603-16. PubMed ID: 12974577 [TBL] [Abstract][Full Text] [Related]
32. A prospective three-dimensional analysis about the impact of differences in the clinical target volume in prostate cancer irradiation on normal-tissue exposure. A potential for increasing the benefit/risk ratio. Hille A; Töws N; Schmidberger H; Hess CF Strahlenther Onkol; 2005 Dec; 181(12):789-95. PubMed ID: 16362789 [TBL] [Abstract][Full Text] [Related]
33. A dose-escalation trial with the adaptive radiotherapy process as a delivery system in localized prostate cancer: analysis of chronic toxicity. Brabbins D; Martinez A; Yan D; Lockman D; Wallace M; Gustafson G; Chen P; Vicini F; Wong J Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):400-8. PubMed ID: 15667959 [TBL] [Abstract][Full Text] [Related]
34. Volume and hormonal effects for acute side effects of rectum and bladder during conformal radiotherapy for prostate cancer. Peeters ST; Hoogeman MS; Heemsbergen WD; Slot A; Tabak H; Koper PC; Lebesque JV Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1142-52. PubMed ID: 15939547 [TBL] [Abstract][Full Text] [Related]
35. A comparative study of rectal dose histograms in prostate brachytherapy: some analytic and numerical results. Song JS; Albert M; D'Amico AV; Cormack RA Med Phys; 2005 Feb; 32(2):437-47. PubMed ID: 15789590 [TBL] [Abstract][Full Text] [Related]
36. Postoperative radiotherapy for prostate cancer: a comparison of four consensus guidelines and dosimetric evaluation of 3D-CRT versus tomotherapy IMRT. Malone S; Croke J; Roustan-Delatour N; Belanger E; Avruch L; Malone C; Morash C; Kayser C; Underhill K; Li Y; Malone K; Nyiri B; Spaans J Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):725-32. PubMed ID: 22444999 [TBL] [Abstract][Full Text] [Related]
37. Assessing correlations between the spatial distribution of the dose to the rectal wall and late rectal toxicity after prostate radiotherapy: an analysis of data from the MRC RT01 trial (ISRCTN 47772397). Buettner F; Gulliford SL; Webb S; Sydes MR; Dearnaley DP; Partridge M Phys Med Biol; 2009 Nov; 54(21):6535-48. PubMed ID: 19826203 [TBL] [Abstract][Full Text] [Related]
38. Spatial features of dose-surface maps from deformably-registered plans correlate with late gastrointestinal complications. Moulton CR; House MJ; Lye V; Tang CI; Krawiec M; Joseph DJ; Denham JW; Ebert MA Phys Med Biol; 2017 May; 62(10):4118-4139. PubMed ID: 28445167 [TBL] [Abstract][Full Text] [Related]
39. The incidence of inclusion of the sigmoid colon and small bowel in the planning target volume in radiotherapy for prostate cancer. De Meerleer GO; Villeirs GM; Vakaet L; Delrue LJ; De Neve WJ Strahlenther Onkol; 2004 Sep; 180(9):573-81. PubMed ID: 15378188 [TBL] [Abstract][Full Text] [Related]
40. Rectum motion and morbidity prediction: Improving correlation between late morbidity and DVH parameters through use of rectum planning organ at risk volumes. Thor M; Væth M; Karlsdottir A; Muren LP Acta Oncol; 2010 Oct; 49(7):1061-8. PubMed ID: 20831497 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]